Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,374,489,548
+$167,936,502 QoQ
Shares Held
24,513,814
-2.5% QoQ
Ownership
4.26%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#4
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,908,415,112 across 370 Biotechnology names. RPRX ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in RPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,374,489,548 | 24,513,814 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,206,553,046 | 25,152,242 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,015,161,979 | 26,272,308 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $987,371,267 | 27,986,714 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,454,092,286 | 40,357,821 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,226,649,412 | 39,404,093 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $672,936,781 | 26,379,333 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $789,012,142 | 27,890,143 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $735,372,302 | 27,886,701 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,021,471,137 | 33,634,216 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $887,192,563 | 31,583,929 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $825,793,446 | 30,427,172 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,041,601,843 | 33,884,250 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,440,627,696 | 39,984,116 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,743,241,622 | 44,110,365 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,726,047,615 | 42,957,880 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,511,478,999 | 35,953,354 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,098,873,070 | 28,205,161 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $879,879,828 | 22,079,795 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $690,626,615 | 19,109,757 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $987,692,128 | 24,095,929 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,219,302,007 | 27,952,820 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,248,374,525 | 24,942,548 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $765,181,947 | 18,188,304 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $794,107,636 | 16,356,491 | Shares | Defined | 2020-08-24 | |
| No filing history on record for this holder in this stock. | ||||||